The Patent Finder

Methods and Compositions for Genomic Integration

Create Medicines, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 3 of these applications claim priority to application PCT/US2020/049240, filed Sep 3, 2020. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
PatentTitleHolderStatusExpiresTime remainingConfidence
US 12,599,678Methods and Compositions for Genomic Integration
In force
 · Low confidence
Create Medicines, Inc.In force
Low confidence
US 11,672,874Methods and Compositions for Genomic Integration
In force
 · Low confidence
Create Medicines, Inc.In force
Low confidence
US 12,766,198Methods and Compositions for Genomic Integration
In force
 · Medium confidence
Create Medicines, Inc.In force
Medium confidence
Application 18/313,087Methods and Compositions for Genomic Integration
Pending
Not granted
Create Medicines, Inc.PendingNot granted
4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
3 of these are in force and held by Create Medicines, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited